FPN || Conferences

Regurgitation controlled by transoral fundoplication

Posted on: 24/10/2014 - 13:39

PHILADELPHIA – The first trial conducted in gastroesophageal reflux diseases that employed control of regurgitation as a primary endpoint found a significant advantage for transoral fundoplication...

Field of Interest: Gastroentero...
Type: News Item

Novel anticoagulants increase GI bleeds in elderly

Posted on: 23/10/2014 - 18:43

PHILADELPHIA – Dabigatran and rivaroxaban, which are rapidly replacing warfarin for anticoagulation in patients with atrial fibrillation, appear to be associated with a greater risk of GI bleeding...

Field of Interest: Gastroentero...
Type: News Item

Select biologics for dose escalation in psoriasis

Posted on: 22/10/2014 - 15:58

SONOMA, CALIF.– Data support dosage escalation or intensification for patients who don’t respond to biologic therapy for psoriasis, but only for three of the four biologic agents available in the...

Field of Interest: Dermatology
Type: News Item

Secukinumab showed sustained efficacy in psoriasis

Posted on: 19/10/2014 - 17:57

AMSTERDAM – The investigational biologic agent secukinumab continued to show strong efficacy through 52 weeks of treatment in a new secondary analysis of the pivotal phase III ERASURE trial. For...

Field of Interest: Dermatology
Type: News Item

In psoriasis, is pushing for PASI 90 really worthwhile?

Posted on: 19/10/2014 - 15:40

AMSTERDAM – Does pushing for a PASI 90 response instead of settling for a PASI 75 matter to patients being treated for moderate-to-severe chronic plaque psoriasis? You bet it does, Dr. Mark G....

Field of Interest: Dermatology
Type: News Item

Drink more coffee to prevent a second BCC

Posted on: 12/10/2014 - 16:53

AMSTERDAM – Liberal coffee consumption was independently associated with a reduced risk of developing a second basal cell carcinoma in individuals who’ve already had a first in an analysis from the...

Field of Interest: Geriatrics
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness